BRAND_ANALYSIS #GLAXOSMITHKLINE HEALTH & PHARMA #2 OF 26 IN HEALTH & PHARMA HIGH TENSION

GlaxoSmithKline

· Public · Updated 09 Apr 2026 08:47 UTC
#9 of 1208 overall by tension · #2 of 26 in Health & Pharma
37 High Tension
The Silent Giant
Analysis

Pharma beige: 77 business, 40 cultural, slightly negative sentiment. The tension score of 37 suggests a brand in perfect equilibrium with public indifference.

IN THE NEWS (37 articles this week)
COPD Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma, AstraZene - Barchart.com
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report - Sahm
The Fair Way: Our Journey to Justice - Lambda Legal
Cultural Score
40 / 100
Business Score
77 / 100
TENSION▃▃▂▂▂▂▃▃▃▃▃▃▃▃
CULTURAL▃▃▃▃▄▄▃▃▃▃▃▃▃▃
BUSINESS▅▅▅▅▅▅▅▅▅▅▆▆▆▆
Loading...
Wikipedia Momentum 15/40
News Presence 26/35
Search InterestRedistributed to other dimensions
Stock Momentum 20/30
Market Position 22/25
Revenue Growth 19/25
Earnings Health 16/20
Price$57.37
30d Change+3.4%
Market Cap$114.6B
Profit Margin17.5%
GlaxoSmithKline's tension is 37. Commerce outpacing culture. sociologyofcapitalism.com/brand/glaxosmithkline
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/glaxosmithkline.html" width="320" height="200" frameborder="0"></iframe>